2 interventions in Supplement graded Early / preclinical.
Alpha-Ketoglutarate (Calcium AKG)
The mouse morbidity-compression data is genuinely interesting, but the headline human claim ('8 years younger') comes from an uncontrolled retrospective methylation-clock analysis of a product sold by the study's backers, which is close to worthless as proof. Intriguing mechanism, marketing that vastly overstates the human evidence.
Fisetin
Marketed as a natural senolytic based almost entirely on one mouse study and cell screens, with essentially no positive human data and a real bioavailability problem. The enthusiasm outruns the evidence badly. Plausible, cheap, low-risk, but 'proven senolytic in people' is not true.